MA33516B1 - Nanoparticules métalliques, leur préparation et leurs utilisations - Google Patents
Nanoparticules métalliques, leur préparation et leurs utilisationsInfo
- Publication number
- MA33516B1 MA33516B1 MA34614A MA34614A MA33516B1 MA 33516 B1 MA33516 B1 MA 33516B1 MA 34614 A MA34614 A MA 34614A MA 34614 A MA34614 A MA 34614A MA 33516 B1 MA33516 B1 MA 33516B1
- Authority
- MA
- Morocco
- Prior art keywords
- nanoparticles
- relates
- preparation
- metal nanoparticles
- nanoparticle
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N2005/1092—Details
- A61N2005/1098—Enhancing the effect of the particle by an injected agent or implanted device
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
La présente invention concerne des nanoparticules activables pouvant être utilisées dans le secteur de la santé, en particulier de la santé humaine, pour perturber, modifier ou détruire des cellules, des tissus ou des organes cibles. Elle concerne plus particulièrement des nanoparticules pouvant générer un effet thérapeutique significativement efficace, lorsqu'elles sont exposées à des radiations ionisantes. La nanoparticule de l'invention est une nanoparticule métallique ayant, comme dimension la plus grande, une taille comprise entre environ 80 et 105 nm, le métal ayant de préférence un numéro atomique (Z) d'au moins 25. L'invention concerne également des compositions pharmaceutiques contenant une population de nanoparticules telles que définies précédemment, ainsi que leurs utilisations.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22457609P | 2009-07-10 | 2009-07-10 | |
EP09165157A EP2275137A1 (fr) | 2009-07-10 | 2009-07-10 | Nanoparticules métalliques, leur préparation et utilisations |
PCT/EP2010/059871 WO2011003999A1 (fr) | 2009-07-10 | 2010-07-09 | Nanoparticules métalliques, leur préparation et leurs utilisations |
Publications (1)
Publication Number | Publication Date |
---|---|
MA33516B1 true MA33516B1 (fr) | 2012-08-01 |
Family
ID=41110399
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA34614A MA33516B1 (fr) | 2009-07-10 | 2012-02-08 | Nanoparticules métalliques, leur préparation et leurs utilisations |
Country Status (25)
Country | Link |
---|---|
US (2) | US9700621B2 (fr) |
EP (3) | EP2275137A1 (fr) |
JP (1) | JP5739883B2 (fr) |
KR (1) | KR101670757B1 (fr) |
CN (1) | CN102470173B (fr) |
AU (1) | AU2010270225B2 (fr) |
BR (2) | BR122019025997B8 (fr) |
CA (1) | CA2765290C (fr) |
CY (1) | CY1118600T1 (fr) |
DK (2) | DK3178494T3 (fr) |
EA (1) | EA020942B1 (fr) |
ES (2) | ES2616628T3 (fr) |
HR (2) | HRP20170175T1 (fr) |
HU (2) | HUE052686T2 (fr) |
IL (1) | IL217287A (fr) |
LT (1) | LT2451481T (fr) |
MA (1) | MA33516B1 (fr) |
MX (2) | MX347606B (fr) |
NZ (1) | NZ597564A (fr) |
PL (2) | PL2451481T3 (fr) |
PT (2) | PT2451481T (fr) |
SG (2) | SG177611A1 (fr) |
SI (1) | SI2451481T1 (fr) |
WO (1) | WO2011003999A1 (fr) |
ZA (1) | ZA201200902B (fr) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112012000311B1 (pt) | 2009-07-08 | 2021-12-21 | Clene Nanomedicine, Inc. | Nanocristais com base em ouro para tratamentos médicos e processos eletroquímicos para a fabricação dos mesmos |
EP2275137A1 (fr) * | 2009-07-10 | 2011-01-19 | Nanobiotix | Nanoparticules métalliques, leur préparation et utilisations |
US20120190979A1 (en) | 2011-01-24 | 2012-07-26 | Actium BioSystems, LLC | System for automatically amending energy field characteristics in the application of an energy field to a living organism for treatment of invasive agents |
AU2012300534B2 (en) * | 2011-08-26 | 2016-12-01 | Endomagnetics Ltd | Apparatus for the generation of an energy field for the treatment of cancer in body cavities and parts that are cavity-like |
WO2013087920A1 (fr) | 2011-12-16 | 2013-06-20 | Nanobiotix | Nanoparticules comprenant des matériaux métalliques et d'oxydes d'hafnium, leur préparation et utilisations |
UA116007C2 (uk) * | 2013-01-25 | 2018-01-25 | Нанобіотікс | Композиції неорганічних наночастинок у комбінації з іонізуючим випромінюванням для лікування раку |
CA2913023C (fr) * | 2013-05-30 | 2021-06-08 | Nanobiotix | Composition pharmaceutique, preparation et utilisations de celle-ci |
JP6560665B2 (ja) * | 2013-06-20 | 2019-08-14 | ナノビオティックスNanobiotix | 医療診断に使用するための組成物および方法 |
TWI689310B (zh) | 2014-07-11 | 2020-04-01 | 巨生生醫股份有限公司 | 治療鐵缺乏症之方法 |
JP6778371B2 (ja) * | 2015-01-23 | 2020-11-04 | ミヨシ油脂株式会社 | 金微粒子マトリックスメタロプロテアーゼ阻害剤 |
AU2016269146B2 (en) | 2015-05-28 | 2021-01-28 | Nanobiotix | Nanoparticles for use as a therapeutic vaccine |
DE102017101057A1 (de) * | 2017-01-20 | 2018-07-26 | Fraunhofer-Institut für Angewandte Polymerforschung IAP | Zwitterionische Nanopartikel |
JP7376901B2 (ja) * | 2017-11-13 | 2023-11-09 | 国立大学法人北海道大学 | 修飾金属ナノ粒子及び医薬組成物 |
CN110883341B (zh) * | 2018-09-11 | 2021-03-30 | 清华大学 | 金纳米团簇制备方法 |
JPWO2021060498A1 (fr) * | 2019-09-27 | 2021-04-01 | ||
KR20230038659A (ko) * | 2020-05-26 | 2023-03-21 | 나노비오띡스 | 나노 입자, 전리 방사선 및 그의 혁신적인 치료용 조합 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000006244A2 (fr) * | 1998-07-30 | 2000-02-10 | Hainfeld James F | Particules metalliques de chargement dans des vesicules membranaires cellulaires et particule metallique utilisee pour l'imagerie et la therapie |
US20070031337A1 (en) * | 2004-06-22 | 2007-02-08 | Reinhard Schulte | Nanoparticle enhanced proton computed tomography and proton therapy |
DE102007040934A1 (de) | 2007-08-30 | 2009-03-05 | Man Diesel A/S | Verfahren und Vorrichtung zur Reinigung von Abgas |
EP2130553A1 (fr) * | 2008-06-05 | 2009-12-09 | Nanobiotix | Nanoparticules inorganiques de haute densité pour détruire des cellules in-vivo |
EP2275137A1 (fr) * | 2009-07-10 | 2011-01-19 | Nanobiotix | Nanoparticules métalliques, leur préparation et utilisations |
-
2009
- 2009-07-10 EP EP09165157A patent/EP2275137A1/fr not_active Withdrawn
-
2010
- 2010-07-09 EP EP10729917.4A patent/EP2451481B1/fr active Active
- 2010-07-09 PT PT107299174T patent/PT2451481T/pt unknown
- 2010-07-09 SG SG2012002044A patent/SG177611A1/en unknown
- 2010-07-09 CA CA2765290A patent/CA2765290C/fr active Active
- 2010-07-09 HU HUE17152585A patent/HUE052686T2/hu unknown
- 2010-07-09 HU HUE10729917A patent/HUE031796T2/en unknown
- 2010-07-09 PT PT171525850T patent/PT3178494T/pt unknown
- 2010-07-09 MX MX2015010613A patent/MX347606B/es unknown
- 2010-07-09 SG SG10201403832YA patent/SG10201403832YA/en unknown
- 2010-07-09 ES ES10729917.4T patent/ES2616628T3/es active Active
- 2010-07-09 ES ES17152585T patent/ES2837412T3/es active Active
- 2010-07-09 WO PCT/EP2010/059871 patent/WO2011003999A1/fr active Application Filing
- 2010-07-09 NZ NZ597564A patent/NZ597564A/xx not_active IP Right Cessation
- 2010-07-09 EA EA201270154A patent/EA020942B1/ru not_active IP Right Cessation
- 2010-07-09 BR BR122019025997A patent/BR122019025997B8/pt not_active IP Right Cessation
- 2010-07-09 JP JP2012519006A patent/JP5739883B2/ja active Active
- 2010-07-09 AU AU2010270225A patent/AU2010270225B2/en not_active Ceased
- 2010-07-09 EP EP17152585.0A patent/EP3178494B1/fr active Active
- 2010-07-09 KR KR1020127003701A patent/KR101670757B1/ko active IP Right Grant
- 2010-07-09 US US13/383,049 patent/US9700621B2/en active Active
- 2010-07-09 DK DK17152585.0T patent/DK3178494T3/da active
- 2010-07-09 PL PL10729917T patent/PL2451481T3/pl unknown
- 2010-07-09 SI SI201031410A patent/SI2451481T1/sl unknown
- 2010-07-09 MX MX2012000285A patent/MX2012000285A/es active IP Right Grant
- 2010-07-09 LT LTEP10729917.4T patent/LT2451481T/lt unknown
- 2010-07-09 PL PL17152585T patent/PL3178494T3/pl unknown
- 2010-07-09 CN CN201080031148.1A patent/CN102470173B/zh active Active
- 2010-07-09 DK DK10729917.4T patent/DK2451481T3/en active
- 2010-07-09 BR BR112012000530A patent/BR112012000530B8/pt not_active IP Right Cessation
-
2011
- 2011-12-29 IL IL217287A patent/IL217287A/en active IP Right Grant
-
2012
- 2012-02-07 ZA ZA2012/00902A patent/ZA201200902B/en unknown
- 2012-02-08 MA MA34614A patent/MA33516B1/fr unknown
-
2017
- 2017-02-02 HR HRP20170175TT patent/HRP20170175T1/hr unknown
- 2017-02-07 CY CY20171100166T patent/CY1118600T1/el unknown
- 2017-06-28 US US15/635,252 patent/US10391174B2/en active Active
-
2020
- 2020-12-15 HR HRP20202005TT patent/HRP20202005T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA33516B1 (fr) | Nanoparticules métalliques, leur préparation et leurs utilisations | |
MA38318A1 (fr) | Compositions de nanoparticules inorganiques combinées à des rayonnements ionisants pour le traitement du cancer | |
Munawer et al. | Biofabrication of gold nanoparticles mediated by the endophytic Cladosporium species: Photodegradation, in vitro anticancer activity and in vivo antitumor studies | |
MA32453B1 (fr) | Manoparticules inograniques, leur preparation et leurs utilisations | |
Barbasz et al. | Toxicity of silver nanoparticles towards tumoral human cell lines U-937 and HL-60 | |
Alarifi et al. | ROS‐mediated apoptosis and genotoxicity induced by palladium nanoparticles in human skin malignant melanoma cells | |
Silva et al. | The effect of silver nanoparticles and nystatin on mixed biofilms of Candida glabrata and Candida albicans on acrylic | |
Vega-Jiménez et al. | Bismuth subsalicylate nanoparticles with anaerobic antibacterial activity for dental applications | |
Ansar et al. | Exposure to zinc oxide nanoparticles induces neurotoxicity and proinflammatory response: amelioration by hesperidin | |
Varmazyari et al. | Cadmium sulfide-induced toxicity in the cortex and cerebellum: In vitro and in vivo studies | |
Sun et al. | Synergy between polyvinylpyrrolidone-coated silver nanoparticles and azole antifungal against drug-resistant Candida albicans | |
ATE487470T1 (de) | Gel-stabilisierte wirkstoff-zusammensetzungen in nanoteilchengrösse | |
Avezov et al. | Oxidative stress in the oral cavity: sources and pathological outcomes | |
Monteiro et al. | Silver colloidal nanoparticle stability: influence on Candida biofilms formed on denture acrylic | |
MX2019013701A (es) | Metodos para mejorar suministro de farmacos y efectividad de agentes terapeuticos. | |
Chang et al. | Toxic mechanisms of Roth801, canals, microparticles and nanoparticles of ZnO on MG-63 osteoblasts | |
Zhang et al. | Antibiofilm activity of ultra-small gold nanoclusters against Fusobacterium nucleatum in dental plaque biofilms | |
Noshy et al. | Alterations in reproductive parameters and steroid biosynthesis induced by nickel oxide nanoparticles in male rats: The ameliorative effect of hesperidin | |
Badoni et al. | Noble metal nanoparticles and graphene oxide based hybrid nanostructures for antibacterial applications: recent advances, synergistic antibacterial activities, and mechanistic approaches | |
Guma et al. | Ex vivo/in vitro effects of aspirin and ibuprofen, bulk and nano forms, in peripheral lymphocytes of prostate cancer patients and healthy individuals | |
Nugroho et al. | L-histidine doped CDs from Zingiber Montanum using hydrothermal method to enhance its antimicrobial activity and imply for latent fingerprint detection | |
Negahdary et al. | Effects of silymarin on oxidative stress markers in rats treated with magnesium oxide nanoparticles | |
Sobhkhizi et al. | Dendrosomal nano-curcumin modulates P-glycoprotein activity and induces apoptosis in wild type and P53-mutant breast cancer cell lines | |
Ahamed et al. | Natural antioxidant curcumin attenuates NiO nanoparticle-induced cytotoxicity in mouse spermatogonia cells: A mechanistic study | |
Ibegbu et al. | Effect of ascorbic acid on mercuric chloride-induced changes on the cerebral cortex of Wistar rats |